Frontiers in Oncology | Cancer Molecular Targets and Therapeutics

Original Research

Published on 28 Jul 2023

WR1065 conjugated to thiol-PEG polymers as novel anticancer prodrugs: broad spectrum efficacy, synergism, and drug resistance reversal

in Cancer Molecular Targets and Therapeutics

Dale M. Walker
Tsvetelina I. Lazarova
Steven W. Riesinger
Miriam C. Poirier
Terri Messier
Brian Cunniff
Vernon E. Walker

Frontiers in Oncology

doi 10.3389/fonc.2023.1212604

4,228 views
1 citation

Review

Published on 28 Jul 2023

The roles of phospholipase C-β related signals in the proliferation, metastasis and angiogenesis of malignant tumors, and the corresponding protective measures

in Cancer Molecular Targets and Therapeutics

Yu-Nuo Wu
Xing Su
Xue-Qin Wang
Na-Na Liu
Zhou-Wei Xu

Frontiers in Oncology

doi 10.3389/fonc.2023.1231875

4,868 views
5 citations

Case Report

Published on 27 Jul 2023

Larotrectinib treatment for infantile fibrosarcoma in newborns: a case report and literature review

in Cancer Molecular Targets and Therapeutics

Dandan Wang
Fanhui Zhang
Wanli Feng
Jiarong Pan
Tianming Yuan

Frontiers in Oncology

doi 10.3389/fonc.2023.1206833

2,779 views
3 citations

Case Report

Published on 21 Jul 2023

An advanced pulmonary sarcomatoid carcinoma patient harboring a BRAFV600E mutation responds to dabrafenib and trametinib: a case report and literature review

in Cancer Molecular Targets and Therapeutics

Ruoxin Fang
Jun Gong
Zhengkai Liao

Frontiers in Oncology

doi 10.3389/fonc.2023.1220745

2,430 views
2 citations

Mini Review

Published on 21 Jul 2023

Circulating circRNA: a social butterfly in tumors

in Cancer Molecular Targets and Therapeutics

Shuo Miao
Qingsong Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1203696

3,408 views
6 citations

Case Report

Published on 11 Jul 2023

Case Report: A rare synchronous multiple gastric carcinoma achieved progression-free disease through NGS-guided serial treatment

in Cancer Molecular Targets and Therapeutics

Xinyi Shao
Jin Yin
Di Wang
Erjiong Huang
Yini Zhang
Jiani C. Yin
Chen Huang
Hao Wu
Xiaoli Wu

Frontiers in Oncology

doi 10.3389/fonc.2023.1195837

2,384 views
1 citation

Brief Research Report

Published on 10 Jul 2023

MACC1 and MET as markers associated with progression and metastasis in cutaneous melanoma

in Cancer Molecular Targets and Therapeutics

Yan Zhou
Cody J. Rasner
Alessio Giubellino

Frontiers in Oncology

doi 10.3389/fonc.2023.1146092

1,763 views
2 citations

Editorial

Published on 07 Jul 2023

Editorial: Women in cancer molecular targets and therapeutics, volume II: 2022

in Cancer Molecular Targets and Therapeutics

Ioana Berindan-Neagoe
Cinzia Lanzi

Frontiers in Oncology

doi 10.3389/fonc.2023.1241793

1,686 views

Original Research

Published on 07 Jul 2023

Cystathionine β-synthase affects organization of cytoskeleton and modulates carcinogenesis in colorectal carcinoma cells

in Cancer Molecular Targets and Therapeutics

Veronika Liskova
Barbora Chovancova
Petr Babula
Ingeborg Rezuchova
Kristina Ploth Pavlov
Miroslava Matuskova
Olga Krizanova

Frontiers in Oncology

doi 10.3389/fonc.2023.1178021

3,397 views
2 citations

Editorial

Published on 07 Jul 2023

Editorial: Patient-derived tumor models for drug development

in Cancer Molecular Targets and Therapeutics

Hatim E. Sabaawy
Massimo Broggini
Shiv K. Gupta

Frontiers in Oncology

doi 10.3389/fonc.2023.1243534

2,387 views
3 citations

Original Research

Published on 05 Jul 2023

Yes-associated protein-1 overexpression in ocular surface squamous neoplasia; a potential diagnostic marker and therapeutic target

in Cancer Molecular Targets and Therapeutics

Peter Julius
Stepfanie N. Siyumbwa
Fred Maate
Phyllis Moonga
Guobin Kang
Trevor Kaile
John T. West
Charles Wood
Peter C. Angeletti

Frontiers in Oncology

doi 10.3389/fonc.2023.1213426

4,250 views
9 citations

Original Research

Published on 04 Jul 2023

Manipulating RKIP reverses the metastatic potential of breast cancer cells

in Cancer Molecular Targets and Therapeutics

Trang Huyen Lai
Mahmoud Ahmed
Jin Seok Hwang
Md Entaz Bahar
Trang Minh Pham
Jinsung Yang
Wanil Kim
Rizi Firman Maulidi
Dong-Kun Lee
Dong-Hee Kim

Frontiers in Oncology

doi 10.3389/fonc.2023.1189350

2,485 views
4 citations

Brief Research Report

Published on 03 Jul 2023

Genomic determinants in advanced endometrial cancer patients with sustained response to hormonal therapy- case series and review of literature

in Cancer Molecular Targets and Therapeutics

Divya Chukkalore
Anisha Rajavel
Divya Asti
Meekoo Dhar

Frontiers in Oncology

doi 10.3389/fonc.2023.1188028

2,756 views
2 citations

Review

Published on 03 Jul 2023

T-cell redirecting therapies for B-cell non-Hodgkin lymphoma: recent progress and future directions

in Cancer Molecular Targets and Therapeutics

David A. Russler-Germain
Armin Ghobadi

Frontiers in Oncology

doi 10.3389/fonc.2023.1168622

11,493 views
10 citations

Review

Published on 30 Jun 2023

Paper-based biosensors as point-of-care diagnostic devices for the detection of cancers: a review of innovative techniques and clinical applications

in Cancer Molecular Targets and Therapeutics

Mehrdad Mahmoodpour
Bahman Abedi Kiasari
Merat Karimi
Arezou Abroshan
Danial Shamshirian
Hamed Hosseinalizadeh
Alireza Delavari
Hamed Mirzei

Frontiers in Oncology

doi 10.3389/fonc.2023.1131435

6,866 views
16 citations

Correction

Published on 27 Jun 2023

Corrigendum: Advanced NSCLC patients with EGFR T790M harbouring TP53 R273C or KRAS G12V cannot benefit from osimertinib based on a clinical multicentre study by tissue and liquid biopsy

in Cancer Molecular Targets and Therapeutics

Yulong Fu
Anqi Wang
Jieqi Zhou
Wei Feng
Minhua Shi
Xiao Xu
Hongqing Zhao
Liming Cai
Jian Feng
Xuedong Lv

Frontiers in Oncology

doi 10.3389/fonc.2023.1236311

1,698 views